Synthetic peptides as the basis for vaccine design.
Arnon
R
R
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins / Q000276:immunology; D001428:Bacterial Vaccines / Q000138:chemical synthesis*; D001483:Base Sequence; D002772:Cholera Toxin / Q000276:immunology; D004768:Enterotoxins / Q000276:immunology; D004926:Escherichia coli / Q000276:immunology; D029968:Escherichia coli Proteins; D005822:Genetic Vectors; D006389:Hemagglutinins, Viral / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology*; D008969:Molecular Sequence Data; D009698:Nucleoproteins / Q000276:immunology; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D022603:Shiga Toxins; D012762:Shigella dysenteriae / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014734:Vibrio cholerae / Q000276:immunology; D014763:Viral Matrix Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000138:chemical synthesis*
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D006389:Hemagglutinins, Viral; D009698:Nucleoproteins; D010455:Peptides; D011993:Recombinant Fusion Proteins; D022603:Shiga Toxins; D014614:Vaccines, Synthetic; D014763:Viral Matrix Proteins; D014765:Viral Vaccines; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli